We overcome current limitations of stem cell research to advance discovery of novel therapeutics and industrial biotechnology products.
We use induced pluripotent stem cell and genome engineering technologies to build the next generation of disease models for drug discovery and regenerative medicine as well as cellular models that emulate the human senses.
As progressive translational research-hub we forge strategic partnerships with industry partners and translate academic achievements and ideas into industrial solutions and products under one roof.
ISAR Translational R&D project competition
ISAR award 2019: Winner of the ISAR translational R&D project competition
Dr. rer. nat. Sarah-Christin Staroßom, Institute for Medical Immunology, Charité – Universitätsmedizin Berlin. ISAR Bioscience is committed to translational R&D in the field of applied stem cell and regenerative medicine research. It is our pleasure to announce that Dr. rer. nat. Sarah-Christin Staroßom is the recipient of the ISAR Award 2019.
ISAR was founded by scientists, drug discovery professionals, and science entrepreneurs. We share the passion that immediate translation of scientific discoveries offers an unprecedented opportunity to discover and develop effective pharmaceutical therapeutics as well as industrial biotechnology products and at the same time enhance economic productivity of knowledge societies.
Translate scientific breakthroughs and ideas into products and solutions at ISAR Bioscience.